AAA
Affinity Asset Advisors’s Apogee Therapeutics APGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30M | Sell |
691,899
-459,300
| -40% | -$19.9M | 4.1% | 7 |
|
|
2025
Q1 | $43M | Buy |
1,151,199
+219,471
| +24% | +$8.2M | 4.1% | 2 |
|
|
2024
Q4 | $42.2M | Buy |
931,728
+267,530
| +40% | +$12.1M | 5.66% | 2 |
|
|
2024
Q3 | $39M | Sell |
664,198
-172,085
| -21% | -$10.1M | 5.32% | 2 |
|
|
2024
Q2 | $32.9M | Buy |
836,283
+244,190
| +41% | +$9.61M | 3.79% | 2 |
|
|
2024
Q1 | $39.3M | Buy |
592,093
+55,000
| +10% | +$3.65M | 4.87% | 1 |
|
|
2023
Q4 | $15M | Sell |
537,093
-508,017
| -49% | -$14.2M | 2.74% | 12 |
|
|
2023
Q3 | $22.3M | Buy |
+1,045,110
| New | +$22.3M | 6.26% | 1 |
|